ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Molecule Targeted Cancer Therapy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-30H13633
Home | Market Reports | Health| Health Conditions| Cancer
Global Small Molecule Targeted Cancer Therapy Market Insights Forecast to 2029
BUY CHAPTERS

Global Small Molecule Targeted Cancer Therapy Market Research Report 2025

Code: QYRE-Auto-30H13633
Report
September 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Roche
Gilead Sciences
Boehringer Ingelheim
Bayer
GSK
Astrazeneca plc
Johnson & Johnson
TEVA
Pfizer Inc
Allergan plc
Merck
Novartis
Sanofi
Amgen Inc
AbbVie
Eli Lilly
Johnson & Johnson

The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years.

Small Molecule Targeted Cancer Therapy Market

Small Molecule Targeted Cancer Therapy Market

The global market for Small Molecule Targeted Cancer Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Most targeted therapies are either small-molecule drugs or monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells. Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Cancer Therapy.
The Small Molecule Targeted Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Targeted Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Targeted Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Small Molecule Targeted Cancer Therapy Market Report

Report Metric Details
Report Name Small Molecule Targeted Cancer Therapy Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Gilead Sciences, Boehringer Ingelheim, Abbott Laboratories, Bayer AG, GSK, AstraZeneca, Johnson & Johnson, Teva, Pfizer, Allergan, Merck, Novartis, Sanofi, Amgen, AbbVie, Eli Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Small Molecule Targeted Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Small Molecule Targeted Cancer Therapy Market report?

Ans: The main players in the Small Molecule Targeted Cancer Therapy Market are Roche, Gilead Sciences, Boehringer Ingelheim, Abbott Laboratories, Bayer AG, GSK, AstraZeneca, Johnson & Johnson, Teva, Pfizer, Allergan, Merck, Novartis, Sanofi, Amgen, AbbVie, Eli Lilly

What are the Application segmentation covered in the Small Molecule Targeted Cancer Therapy Market report?

Ans: The Applications covered in the Small Molecule Targeted Cancer Therapy Market report are Lymphoma, Melanoma, Multiple Myeloma, Breast Cancer, Prostate Cancer, Others

What are the Type segmentation covered in the Small Molecule Targeted Cancer Therapy Market report?

Ans: The Types covered in the Small Molecule Targeted Cancer Therapy Market report are Monoclonal Antibodies, Small Molecules, Small Molecule Drug Conjugates

Recommended Reports

Targeted Cancer Therapies

Small Molecule Drugs

Cancer Immunotherapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecules
1.2.4 Small Molecule Drug Conjugates
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2020-2031)
2.2 Global Small Molecule Targeted Cancer Therapy Growth Trends by Region
2.2.1 Global Small Molecule Targeted Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule Targeted Cancer Therapy Market Dynamics
2.3.1 Small Molecule Targeted Cancer Therapy Industry Trends
2.3.2 Small Molecule Targeted Cancer Therapy Market Drivers
2.3.3 Small Molecule Targeted Cancer Therapy Market Challenges
2.3.4 Small Molecule Targeted Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue
3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Targeted Cancer Therapy Revenue
3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2024
3.5 Global Key Players of Small Molecule Targeted Cancer Therapy Head office and Area Served
3.6 Global Key Players of Small Molecule Targeted Cancer Therapy, Product and Application
3.7 Global Key Players of Small Molecule Targeted Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
6.2 North America Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
9.2 Latin America Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Small Molecule Targeted Cancer Therapy Introduction
11.1.4 Roche Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Small Molecule Targeted Cancer Therapy Introduction
11.2.4 Gilead Sciences Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Introduction
11.3.4 Boehringer Ingelheim Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
11.4.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.4.5 Abbott Laboratories Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Small Molecule Targeted Cancer Therapy Introduction
11.5.4 Bayer AG Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.5.5 Bayer AG Recent Development
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Small Molecule Targeted Cancer Therapy Introduction
11.6.4 GSK Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.6.5 GSK Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Small Molecule Targeted Cancer Therapy Introduction
11.7.4 AstraZeneca Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Small Molecule Targeted Cancer Therapy Introduction
11.8.4 Johnson & Johnson Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.8.5 Johnson & Johnson Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Small Molecule Targeted Cancer Therapy Introduction
11.9.4 Teva Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Small Molecule Targeted Cancer Therapy Introduction
11.10.4 Pfizer Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Allergan
11.11.1 Allergan Company Details
11.11.2 Allergan Business Overview
11.11.3 Allergan Small Molecule Targeted Cancer Therapy Introduction
11.11.4 Allergan Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.11.5 Allergan Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Small Molecule Targeted Cancer Therapy Introduction
11.12.4 Merck Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Small Molecule Targeted Cancer Therapy Introduction
11.13.4 Novartis Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.13.5 Novartis Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Small Molecule Targeted Cancer Therapy Introduction
11.14.4 Sanofi Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.14.5 Sanofi Recent Development
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Small Molecule Targeted Cancer Therapy Introduction
11.15.4 Amgen Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.15.5 Amgen Recent Development
11.16 AbbVie
11.16.1 AbbVie Company Details
11.16.2 AbbVie Business Overview
11.16.3 AbbVie Small Molecule Targeted Cancer Therapy Introduction
11.16.4 AbbVie Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.16.5 AbbVie Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly Small Molecule Targeted Cancer Therapy Introduction
11.17.4 Eli Lilly Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.17.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Roche
Gilead Sciences
Boehringer Ingelheim
Bayer
GSK
Astrazeneca plc
Johnson & Johnson
TEVA
Pfizer Inc
Allergan plc
Merck
Novartis
Sanofi
Amgen Inc
AbbVie
Eli Lilly
Johnson & Johnson
List of Tables
 Table 1. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Small Molecules
 Table 4. Key Players of Small Molecule Drug Conjugates
 Table 5. Global Small Molecule Targeted Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Small Molecule Targeted Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2020-2025)
 Table 9. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2026-2031)
 Table 11. Small Molecule Targeted Cancer Therapy Market Trends
 Table 12. Small Molecule Targeted Cancer Therapy Market Drivers
 Table 13. Small Molecule Targeted Cancer Therapy Market Challenges
 Table 14. Small Molecule Targeted Cancer Therapy Market Restraints
 Table 15. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Small Molecule Targeted Cancer Therapy Market Share by Players (2020-2025)
 Table 17. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2024)
 Table 18. Ranking of Global Top Small Molecule Targeted Cancer Therapy Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Small Molecule Targeted Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Small Molecule Targeted Cancer Therapy, Headquarters and Area Served
 Table 21. Global Key Players of Small Molecule Targeted Cancer Therapy, Product and Application
 Table 22. Global Key Players of Small Molecule Targeted Cancer Therapy, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2020-2025)
 Table 26. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2026-2031)
 Table 28. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2020-2025)
 Table 30. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2026-2031)
 Table 32. North America Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Roche Company Details
 Table 48. Roche Business Overview
 Table 49. Roche Small Molecule Targeted Cancer Therapy Product
 Table 50. Roche Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 51. Roche Recent Development
 Table 52. Gilead Sciences Company Details
 Table 53. Gilead Sciences Business Overview
 Table 54. Gilead Sciences Small Molecule Targeted Cancer Therapy Product
 Table 55. Gilead Sciences Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 56. Gilead Sciences Recent Development
 Table 57. Boehringer Ingelheim Company Details
 Table 58. Boehringer Ingelheim Business Overview
 Table 59. Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Product
 Table 60. Boehringer Ingelheim Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 61. Boehringer Ingelheim Recent Development
 Table 62. Abbott Laboratories Company Details
 Table 63. Abbott Laboratories Business Overview
 Table 64. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product
 Table 65. Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 66. Abbott Laboratories Recent Development
 Table 67. Bayer AG Company Details
 Table 68. Bayer AG Business Overview
 Table 69. Bayer AG Small Molecule Targeted Cancer Therapy Product
 Table 70. Bayer AG Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 71. Bayer AG Recent Development
 Table 72. GSK Company Details
 Table 73. GSK Business Overview
 Table 74. GSK Small Molecule Targeted Cancer Therapy Product
 Table 75. GSK Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 76. GSK Recent Development
 Table 77. AstraZeneca Company Details
 Table 78. AstraZeneca Business Overview
 Table 79. AstraZeneca Small Molecule Targeted Cancer Therapy Product
 Table 80. AstraZeneca Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 81. AstraZeneca Recent Development
 Table 82. Johnson & Johnson Company Details
 Table 83. Johnson & Johnson Business Overview
 Table 84. Johnson & Johnson Small Molecule Targeted Cancer Therapy Product
 Table 85. Johnson & Johnson Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 86. Johnson & Johnson Recent Development
 Table 87. Teva Company Details
 Table 88. Teva Business Overview
 Table 89. Teva Small Molecule Targeted Cancer Therapy Product
 Table 90. Teva Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 91. Teva Recent Development
 Table 92. Pfizer Company Details
 Table 93. Pfizer Business Overview
 Table 94. Pfizer Small Molecule Targeted Cancer Therapy Product
 Table 95. Pfizer Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 96. Pfizer Recent Development
 Table 97. Allergan Company Details
 Table 98. Allergan Business Overview
 Table 99. Allergan Small Molecule Targeted Cancer Therapy Product
 Table 100. Allergan Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 101. Allergan Recent Development
 Table 102. Merck Company Details
 Table 103. Merck Business Overview
 Table 104. Merck Small Molecule Targeted Cancer Therapy Product
 Table 105. Merck Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 106. Merck Recent Development
 Table 107. Novartis Company Details
 Table 108. Novartis Business Overview
 Table 109. Novartis Small Molecule Targeted Cancer Therapy Product
 Table 110. Novartis Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 111. Novartis Recent Development
 Table 112. Sanofi Company Details
 Table 113. Sanofi Business Overview
 Table 114. Sanofi Small Molecule Targeted Cancer Therapy Product
 Table 115. Sanofi Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 116. Sanofi Recent Development
 Table 117. Amgen Company Details
 Table 118. Amgen Business Overview
 Table 119. Amgen Small Molecule Targeted Cancer Therapy Product
 Table 120. Amgen Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 121. Amgen Recent Development
 Table 122. AbbVie Company Details
 Table 123. AbbVie Business Overview
 Table 124. AbbVie Small Molecule Targeted Cancer Therapy Product
 Table 125. AbbVie Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 126. AbbVie Recent Development
 Table 127. Eli Lilly Company Details
 Table 128. Eli Lilly Business Overview
 Table 129. Eli Lilly Small Molecule Targeted Cancer Therapy Product
 Table 130. Eli Lilly Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 131. Eli Lilly Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Small Molecule Targeted Cancer Therapy Picture
 Figure 2. Global Small Molecule Targeted Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Small Molecule Targeted Cancer Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Small Molecules Features
 Figure 6. Small Molecule Drug Conjugates Features
 Figure 7. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2024 VS 2031
 Figure 9. Lymphoma Case Studies
 Figure 10. Melanoma Case Studies
 Figure 11. Multiple Myeloma Case Studies
 Figure 12. Breast Cancer Case Studies
 Figure 13. Prostate Cancer Case Studies
 Figure 14. Others Case Studies
 Figure 15. Small Molecule Targeted Cancer Therapy Report Years Considered
 Figure 16. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Small Molecule Targeted Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Small Molecule Targeted Cancer Therapy Market Share by Region: 2024 VS 2031
 Figure 19. Global Small Molecule Targeted Cancer Therapy Market Share by Players in 2024
 Figure 20. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2024
 Figure 22. North America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
 Figure 24. United States Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
 Figure 28. Germany Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Region (2020-2031)
 Figure 36. China Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
 Figure 44. Mexico Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
 Figure 48. Turkey Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Roche Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 52. Gilead Sciences Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 53. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 54. Abbott Laboratories Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 55. Bayer AG Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 56. GSK Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 57. AstraZeneca Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 58. Johnson & Johnson Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 59. Teva Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 60. Pfizer Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 61. Allergan Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 62. Merck Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 63. Novartis Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 64. Sanofi Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 65. Amgen Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 66. AbbVie Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 67. Eli Lilly Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Small Molecule Targeted Anti cancer Drug Market Insights Forecast to 2030
Global Targeted Small Molecule Drug Market Research Report 2025
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Small Molecule Targeted Therapy Market Insights Forecast to 2030
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Small Molecule Cancer Drug Market Research Report 2025
Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024
Global Commercialized Small Molecule for Therapy Market Research Report 2024
Global Cancer Targeted Drug Market Research Report 2025
Global Targeted Cancer Therapy Market Research Report 2024
Global Oncology Targeted Therapy Market Research Report 2025
Targeting Small Molecule Tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Oncology Drugs Market Research Report 2024
Global Oncology Small Molecule Drugs Market Insights Forecast to 2030
Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Small Molecule Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Antitumor Drugs Market Research Report 2025
Global Targeted Drugs for Breast Cancer Market Research Report 2024

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions